GLYCEROL PHENYLBUTYRATE
| Brand name | RAVICTI |
|---|---|
| Active ingredient | GLYCEROL PHENYLBUTYRATE |
| Strength | 1.1GM/ML |
| Dosage form | LIQUID |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | February 2013 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9561197 | September 2030 | use U-1383 |
| 10183003 | September 2030 | use U-1816 |
| 10183002 | September 2030 | use U-1816 |
| 10183004 | September 2030 | use U-1816 |
| 8642012 | September 2030 | use U-1383 |
| 10045959 | September 2030 | use U-1816 |
| 9962359 | September 2030 | use U-1816 |
| 9326966 | September 2030 | use U-1816 |
| 10668040 | September 2030 | use U-1816 |
| 10183005 | September 2030 | use U-1816 |
| 10183006 | September 2030 | use U-1816 |
| 10045958 | September 2030 | use U-1816 |
| 9254278 | September 2030 | use U-1816 |
| 9999608 | September 2030 | use U-1816 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.